MSGS Q1 2026 Earnings EPS Falls Well Below Estimates as Stock Holds Steady ADXN Q1 2024 Earnings EPS Reported at 1227 No Revenue as DevelopmentStage Biotech Continues LivaNova Q1 2026 Earnings EPS Beats Estimates by 71 as Company Highlights Operational Efficiencies RITM Q1 2026 Earnings Modest EPS Beat Highlights Stability in Mortgage Real Estate SMC Q1 2026 Earnings EPS Beats Estimates but Stock Declines 778 Fulcrum Therapeutics FULC Q1 2026 Earnings NarrowerthanExpected Loss Despite Mild Stock Dip ZWS Q1 2026 Earnings EPS Surges Past Estimates with 116 Beat Ocular Therapeutix Q1 2026 Earnings EPS Misses Estimates as RD Investments Continue RDZN Q1 2026 Earnings Significant EPS Miss Highlights Ongoing Challenges SFM Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency Dyne Therapeutics Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Focus MGPI Q1 2026 Earnings Earnings Surge Past Estimates with 308 Surprise ENS Q1 2026 Earnings EPS Beats Estimates but Stock Slips